Literature DB >> 29597356

Complement Factor D protects mice from ethanol-induced inflammation and liver injury.

Rebecca L McCullough1, Megan R McMullen1, Megan M Sheehan1, Kyle L Poulsen1, Sanjoy Roychowdhury1, Dian J Chiang2, Michele T Pritchard3, Juan Caballeria4, Laura E Nagy1,5.   

Abstract

Complement plays a crucial role in microbial defense and clearance of apoptotic cells. Emerging evidence suggests complement is an important contributor to alcoholic liver disease. While complement component 1, Q subcomponent (C1q)-dependent complement activation contributes to ethanol-induced liver injury, the role of the alternative pathway in ethanol-induced injury is unknown. Activation of complement via the classical and alternative pathways was detected in alcoholic hepatitis patients. Female C57BL/6J [wild type (WT)], C1q-deficient ( C1qa-/-, lacking classical pathway activation), complement protein 4-deficient ( C4-/-, lacking classical and lectin pathway activation), complement factor D-deficient ( FD-/-, lacking alternative pathway activation), and C1qa/FD-/- (lacking classical and alternative pathway activation) mice were fed an ethanol-containing liquid diet or pair-fed control diet for 4 or 25 days. Following chronic ethanol exposure, liver injury, steatosis, and proinflammatory cytokine expression were increased in WT but not C1qa-/-, C4-/-, or C1qa/FD-/- mice. In contrast, liver injury, steatosis, and proinflammatory mediators were robustly increased in ethanol-fed FD-/- mice compared with WT mice. Complement activation, assessed by hepatic accumulation of C1q and complement protein 3 (C3) cleavage products (C3b/iC3b/C3c), was evident in livers of WT mice in response to both short-term and chronic ethanol. While C1q accumulated in ethanol-fed FD-/- mice (short term and chronic), C3 cleavage products were detected after short-term but not chronic ethanol. Consistent with impaired complement activation, chronic ethanol induced the accumulation of apoptotic cells and fibrogenic responses in the liver of FD-/- mice. These data highlight the protective role of complement factor D (FD) and suggest that FD-dependent amplification of complement is an adaptive response that promotes hepatic healing and recovery in response to chronic ethanol. NEW & NOTEWORTHY Complement, a component of the innate immune system, is an important pathophysiological contributor to ethanol-induced liver injury. We have identified a novel role for factor D, a component of the alternative pathway, in protecting the liver from ethanol-induced inflammation, accumulation of apoptotic hepatocytes, and profibrotic responses. These data indicate a dual role of complement with regard to inflammatory and protective responses and suggest that accumulation of apoptotic cells impairs hepatic healing/recovery during alcoholic liver disease.

Entities:  

Keywords:  alcoholic liver disease; apoptosis; steatosis

Mesh:

Substances:

Year:  2018        PMID: 29597356      PMCID: PMC6109707          DOI: 10.1152/ajpgi.00334.2017

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  57 in total

Review 1.  The central role of the alternative complement pathway in human disease.

Authors:  Joshua M Thurman; V Michael Holers
Journal:  J Immunol       Date:  2006-02-01       Impact factor: 5.422

Review 2.  Role of complement and complement regulators in the removal of apoptotic cells.

Authors:  L A Trouw; A M Blom; P Gasque
Journal:  Mol Immunol       Date:  2007-10-24       Impact factor: 4.407

3.  C5aR and C5L2 act in concert to balance immunometabolism in adipose tissue.

Authors:  Pegah Poursharifi; Marc Lapointe; Alexandre Fisette; Huiling Lu; Christian Roy; Mercedes Nancy Munkonda; David P Fairlie; Katherine Cianflone
Journal:  Mol Cell Endocrinol       Date:  2013-10-25       Impact factor: 4.102

4.  Plasminogen activators direct reorganization of the liver lobule after acute injury.

Authors:  J A Bezerra; A R Currier; H Melin-Aldana; G Sabla; T H Bugge; K W Kombrinck; J L Degen
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

5.  MicroRNA 181b-3p and its target importin α5 regulate toll-like receptor 4 signaling in Kupffer cells and liver injury in mice in response to ethanol.

Authors:  Paramananda Saikia; Damien Bellos; Megan R McMullen; Katherine A Pollard; Carol de la Motte; Laura E Nagy
Journal:  Hepatology       Date:  2017-07-04       Impact factor: 17.425

Review 6.  Advances in alcoholic liver disease: An update on alcoholic hepatitis.

Authors:  Randy Liang; Andy Liu; Ryan B Perumpail; Robert J Wong; Aijaz Ahmed
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

7.  Activation of the complement system in human nonalcoholic fatty liver disease.

Authors:  Sander S Rensen; Yanti Slaats; Ann Driessen; Carine J Peutz-Kootstra; Jeroen Nijhuis; Rudi Steffensen; Jan Willem Greve; Wim A Buurman
Journal:  Hepatology       Date:  2009-12       Impact factor: 17.425

8.  Effect of chronic ethanol consumption on the expression of complement components and acute-phase proteins in liver.

Authors:  Igor Bykov; Sami Junnikkala; Marcela Pekna; Kai O Lindros; Seppo Meri
Journal:  Clin Immunol       Date:  2007-06-22       Impact factor: 3.969

9.  Complement alternative pathway activation in human nonalcoholic steatohepatitis.

Authors:  Filip M Segers; Froukje J Verdam; Charlotte de Jonge; Bas Boonen; Ann Driessen; Ronit Shiri-Sverdlov; Nicole D Bouvy; Jan Willem M Greve; Wim A Buurman; Sander S Rensen
Journal:  PLoS One       Date:  2014-10-09       Impact factor: 3.240

Review 10.  Alcoholic, Nonalcoholic, and Toxicant-Associated Steatohepatitis: Mechanistic Similarities and Differences.

Authors:  Swati Joshi-Barve; Irina Kirpich; Matthew C Cave; Luis S Marsano; Craig J McClain
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2015-06-03
View more
  17 in total

Review 1.  Inflammatory pathways in alcoholic steatohepatitis.

Authors:  Bin Gao; Maleeha F Ahmad; Laura E Nagy; Hidekazu Tsukamoto
Journal:  J Hepatol       Date:  2019-02       Impact factor: 25.083

2.  The non-transcriptional activity of IRF3 modulates hepatic immune cell populations in acute-on-chronic ethanol administration in mice.

Authors:  Carlos Sanz-Garcia; Kyle L Poulsen; Damien Bellos; Han Wang; Megan R McMullen; Xiaoxia Li; Saurabh Chattopadhyay; Ganes Sen; Laura E Nagy
Journal:  J Hepatol       Date:  2019-01-31       Impact factor: 25.083

3.  Anthocyanins regulate serum adipsin and visfatin in patients with prediabetes or newly diagnosed diabetes: a randomized controlled trial.

Authors:  Liping Yang; Yun Qiu; Wenhua Ling; Zhaomin Liu; Lili Yang; Changyi Wang; Xiaolin Peng; Li Wang; Jianying Chen
Journal:  Eur J Nutr       Date:  2020-09-15       Impact factor: 5.614

Review 4.  The endocrine function of adipose tissues in health and cardiometabolic disease.

Authors:  Ludger Scheja; Joerg Heeren
Journal:  Nat Rev Endocrinol       Date:  2019-07-11       Impact factor: 43.330

5.  Diagnostic and Prognostic Significance of Complement in Patients With Alcohol-Associated Hepatitis.

Authors:  Xiude Fan; Rebecca L McCullough; Emily Huang; Annette Bellar; Adam Kim; Kyle L Poulsen; Craig J McClain; Mack Mitchell; Arthur J McCullough; Svetlana Radaeva; Bruce Barton; Gyongyi Szabo; Srinivasan Dasarathy; Daniel M Rotroff; Laura E Nagy
Journal:  Hepatology       Date:  2020-11-22       Impact factor: 17.425

6.  Tamarix chinensis Lour inhibits chronic ethanol-induced liver injury in mice.

Authors:  Zhi-Dan Wang; Yu Zhang; Yi-Dan Dai; Ke Ren; Chen Han; Heng-Xiao Wang; Shuang-Qin Yi
Journal:  World J Gastroenterol       Date:  2020-03-28       Impact factor: 5.742

7.  HFD-induced hepatic lipid accumulation and inflammation are decreased in Factor D deficient mouse.

Authors:  Hiromi Tsuru; Mizuko Osaka; Yuichi Hiraoka; Masayuki Yoshida
Journal:  Sci Rep       Date:  2020-10-16       Impact factor: 4.379

8.  Anaphylatoxin Receptors C3aR and C5aR1 Are Important Factors That Influence the Impact of Ethanol on the Adipose Secretome.

Authors:  Rebecca L McCullough; Megan R McMullen; Kyle L Poulsen; Adam Kim; M Edward Medof; Laura E Nagy
Journal:  Front Immunol       Date:  2018-09-20       Impact factor: 7.561

Review 9.  Complements are involved in alcoholic fatty liver disease, hepatitis and fibrosis.

Authors:  Cheng-Jie Lin; Zhi-Gao Hu; Guan-Dou Yuan; Biao Lei; Song-Qing He
Journal:  World J Hepatol       Date:  2018-10-27

10.  Tert-butylhydroquinone mitigates Carbon Tetrachloride induced Hepatic Injury in mice.

Authors:  Ruidong Li; Peng Zhang; Chengguo Li; Wenchang Yang; Yuping Yin; Kaixiong Tao
Journal:  Int J Med Sci       Date:  2020-07-29       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.